Preferences help
enabled [disable] Abstract
Number of results
2012 | 59 | 4 | 495-499
Article title

Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke - pathogenic and therapeutic implications

Title variants
Languages of publication
Stroke is one of the most devastating neurological conditions, with an approximate worldwide mortality of 5.5 million annually and loss of 44 million disability-adjusted life-years. The etiology of stroke is often unknown; it has been estimated that the etiology and pathophysiology remains unexplained in more than 40% of stroke cases. The conventional stroke risk factors, including hypertension, diabetes mellitus, smoking, and cardiac diseases, do not fully account for the risk of stroke, and stroke victims, especially young subjects, often do not have any of these factors. It is very likely that inflammation, specific genetic predispositions and traditional risk factors interact with each other and may together increase the risk of stroke. Inflammatory and immune responses play important roles in the course of ischemic stroke. Hyperhomocysteinemia (hcy) is considered a modifiable risk factor for stroke, possibly through an atherogenic and prothrombotic mechanism. Both genetic and environmental factors (e.g., dietary intake of folic acid and B vitamins) affect homocysteine level. Identification of the role of hcy as a modifiable risk factor for stroke and of HSPs as regulators of the immune response may lead to more effective prevention and treatment of stroke through dietary and pharmacological intervention. Dietary modification may also include supplementation with novel preventive compounds, such as the antioxidative isoflavones - genistein or daidzein.
Physical description
  • Department of Neurology, Medical University of Gdańsk, Gdańsk, Poland
  • Department of Molecular and Cellular Biology, Intercollegiate Faculty of Biotechnology UG and MUG, Gdańsk, Poland
  • Department of Molecular and Cellular Biology" country="Intercollegiate Faculty of Biotechnology UG and MUG, Gdańsk, Poland
  • Department of Microbiology, University of Szczecin, Szczecin, Poland
  • Department of Molecular and Cellular Biology, Intercollegiate Faculty of Biotechnology UG and MUG, Gdańsk, Poland
  • Becker JS, Adler A, Schneeberger A, Huang H, Wang Z, Walsh E, Koller A, Hintze TH (2005) Hyperhomocysteinemia, a cardiac metabolic disease role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation 111: 2112-2118.
  • Benarroch EE (2011) Heat shock proteins: Multiple neuroprotective functions and implications for neurologic disease . Neurology 76: 660-667.
  • Blackwell S (2010) The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Ann Clin Biochem 47: 17-28.
  • Chen J., Simon R (1997) Ischemic tolerance in the brain. Neurology 48: 306-311.
  • Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H (2007) Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J 21: 1707-1713.
  • Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G (2000) Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26: 243-254.
  • Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109: III-27-III-32.
  • Elkind MS (2010) Inflammatory mechanisms of stroke. Stroke 41 (Suppl 1): S3-S8.
  • Finkelstein JD (1998) The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157: S40-Z44.
  • Georgopoulos C, Welch WJ (1993) Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 9: 601-634.
  • Gibbs RG, Sian M, Mitchell AW, Greenhalgh RM, Davies AH, Carey N (2000) Chlamydia pneumoniae does not influence atherosclerotic plaquebehavior in patients with established carotid stenosis. Stroke 31: 2930-2935.
  • Godzik KL, O'Brien ER, Wang SK, Kuo CC (1995) In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 33: 2411-2414.
  • Grayston JT (2000) Background and current knowledge of Chlamydia pneumonia and atherosclerosis. J Infect Dis 181: S402-S410.
  • Gromadzka G, Zielinska J, Ryglewicz D, Fiszer U, Czlonkowska A (2001) Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. Cerebrovasc Dis 12: 235-239.
  • Hadithi M, Mulder CJ, Stam F, Azizi J, Crusius JB, Peña AS, Stehouwer CD, Smulders YM (2009) Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease. World J Gastroenterol 15: 955-960.
  • Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519.
  • Hayden MR, Tyagi SC (2003) Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation. Nutr J 3: 4.
  • Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21.
  • Jakóbkiewicz-Banecka J, Kloska A, Stepnowska M, Banecki B, Węgrzyn A, Węgrzyn G (2005) A bacterial model for studying effects of human mutations in vivo: Escherichia coli strains mimicking a common polymorphism in the human MTHFR gene. Mutation Res 578: 175-186.
  • Jakubowski H (2001) Protein N-homocysteinylation: implications for atherosclerosis. Biomed Pharmacother 55: 443-447.
  • Jakubowski H (2007) The pathophysiological hypothesis of homocysteine thiolactonemediated vascular disease. J Physiol Pharmacol 59: 155-167.
  • Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, Wang H (2005) Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25: 2515-2521.
  • Jickling GC, Zhan X, Stamova B, Bradley PA, Yingfang T, Dazhi L, Sison SM, Verro P, Johnston CS, Sharp FR (2012) Ischemic transient neurological events identified by immune response to cerebral ischemia. Stroke 43: 1006-1012.
  • Kabakov AE, Gabai VL (1995) Heat shock-induced accumulation of 70-kda stress protein (hsp70) can protect ATP-depleted tumor cells from necrosis. Exp Cell Res 217: 15-21.
  • Kaul S, Zadeh AA, Shah PK (2006) Homocysteine hypothesis for atherothrombotic cardiovascular disease. J Am Coll Cardiol 48: 914-923.
  • Kocaman SA (2009) Asymmetric dimethylarginine, NO and collateral growth. Anadolu Kardiyol Derg 9: 417-420.
  • Kogure K, Kato H (1993) Altered gene expression in cerebral ischemia. Stroke 24: 2121-2127.
  • Kolling J, Scherer E, da Cunha A, da Cunha M, Wyse A (2011) Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 11: 67-73.
  • Lee ME, Wang H (1999) Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc Med 9: 49-54.
  • Lee SH, Kwon HM, Kim YJ, Lee KM, Kim M, Yoon BW (2004) Effects of HSP70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke 35: 2195-2199.
  • Lentz SR (1997) Homocysteine and vascular dysfunction. Life Sci 61: 1205-1215.
  • Lindsberg P, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34: 2518-2532.
  • Mandal K, Jahangiri M, Xu Q (2004) Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 3: 31-37.
  • Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH (1995) Overexpression of the rat inducible 70-kd heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95: 1446-1456.
  • McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128.
  • Mehta TA, Greenman J, Ettelaie C, Venkatasubramaniam A, Chetter IC, McCollum PT (2005) Heat Shock proteins in vascular disease - a review. Eur J Vasc Endovasc Surg 29: 395-402.
  • Mosorin M, Surcel HM, Laurila A, Lehtinen M, Karttunen R, Juvonen J, Paavonen J, Morrison RP, Saikku P, Juvonen T (2000) Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 20: 1061-1067.
  • Palanisamy N, Viswanathan P, Anuradha CV (2008) Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Ren Fail 30: 645-654.
  • Palanisamy N, Venkataraman AC (2012) Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructosefed hypertensive rats. Br J Nutr PMID 23116847.
  • Pan W, Ikeda K, Takebe M, Yamori Y (2001) Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Nutr 131: 1154-1158.
  • Papapetropoulos A, García-Cardena G, Madri JA, Sessa WC (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139.
  • Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, De Santo NG (2003) Possible mechanisms of homocysteine toxicity. Kidney Int Suppl 84: S137-S140.
  • Lindsberg PJ, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34: 2518-2532.
  • Pockley GA (2003) Heat shock proteins as regulators of the immune response. Lancet 362: 469-476.
  • Rajdev S, Hara K, Kokubo Y, Mestril R, Dillmann W, Weinstein PR, Sharp FR (2000) Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann Neurol 47: 782-791.
  • Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-985.
  • Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B (2008) Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochim Pol 55: 119-125.
  • Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B (2009) Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland. Clin Biochem 42: 442-447.
  • Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL (1999) Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131: 331-339.
  • Terwecoren A, Steen E, Benoit D, Boon P, Hemelsoet D (2009) Ischemic stroke and hyperhomocysteinemia: truth or myth? Acta Neurol Belg 109: 181-188.
  • Trieu VN, Dong Y, Zheng Y, Uckun FM (1999) In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke. Radiat Res 152: 508-516.
  • Tsai JC, Perrella MA, Yoshizumi M , Hsieh CM, Haber E, Schlegel R, Lee ME (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91: 6369-6373.
  • Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39: 1764-1779.
  • Wang H, Murphy PA (1994) Isoflavone content in commercial soybean foods. J Agric Food Chem 42: 1666-1673.
  • Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172.
  • Welch GN, Upchurch GR Jr, Loscalzo J (1997) Homocysteine, oxidative stress, and vascular disease. Hosp Pract 32: 81-82.
  • Welch NG, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050.
  • Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC (2001) Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107: 1263-1273.
  • Wick G, Perschinka H, Millonig G (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol 22: 665-669.
  • Xu JW, Ikeda K, Yamori Y (2004) Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27: 675-683.
  • Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G (1993) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341: 255-259.
  • Xiao Q, Mandal K, Schett G, Mayr M, Wick G, Oberhollenzer F, Willeit J, Kiechl S, Xu Q (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study stroke. Stroke 36: 2571-2576.
  • Zeng X, Dai J, Remick DG, Wang X (2003) Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 93: 311-320.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.